All Stories

  1. Is the light at the end of the tunnel nigh? A review of ADPKD focusing on the burden of disease and tolvaptan as a new treatment

    Article • International Journal of Nephrology and Renovascular Disease, February 2018, Dove Medical Press

    Rahaf Attar